(a) The following persons, or their designees, shall be members of the Drug Overdose Fatality Review Commission (“the Commission”) by virtue of position:
(1) The Delaware Attorney General.
(2) The Secretary of the State Department of Health and Social Services.
(3) The Director of the Delaware Division of Forensic Science.
(4) The Secretary of Safety and Homeland Security.
(5) The Director of the Delaware Division of Public Health.
(6) The Commissioner of the Delaware Department of Correction.
(b) The following persons shall be appointed by the Governor as members of the Commission:
(1) Two representatives of the Medical Society of Delaware.
(2) A representative of the Delaware Nurses Association.
(3) A representative of the Police Chiefs Council of Delaware who is an active law-enforcement officer.
(4) A representative of the Delaware Fraternal Order of Police who is an active law-enforcement officer.
(5) Two advocates from statewide nonprofit organizations.
(6) A representative of the Delaware Healthcare Association.
(c) The chairperson of each regional review team established pursuant to subsection (g) of this section shall also serve as a member of the Commission.
(d) The term of members appointed by the Governor shall be 3 years and shall terminate upon the Governor's appointment of a new member to the Commission. The members of the Commission and regional review teams shall serve without compensation. The Commission shall be staffed by the Delaware Department of Justice.
(e) The Commission shall, by affirmative vote of a majority of all members of the Commission, appoint a chairperson from its membership for a term of 1 year.
(f) Meetings of the Commission and regional review teams shall be closed to the public.
(g) The Commission shall by resolution passed by a majority of its members establish 3 regional review teams authorized to review overdose deaths. Members of the Commission shall appoint representatives to each review team such that the review team reflects the disciplines of the Commission.